BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 20037337)

  • 1. [A local control trial of skin malignant tumor].
    Enomoto K; Sakurai K; Amano S; Shiono M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2102-4. PubMed ID: 20037337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic mapping and sentinel lymph node biopsy for malignant melanoma in Japanese.
    Motomura H; Ishii M
    Osaka City Med J; 2004 Jun; 50(1):29-37. PubMed ID: 15646256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sentinel lymph node biopsy in patients with cutaneous malignant melanoma].
    Gad D; Sjøgren P
    Ugeskr Laeger; 2003 Jun; 165(25):2567-70. PubMed ID: 12854268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Feasibility and technical problems of sentinel node analysis in melanoma].
    Mebazaa A; Kerob D; Toubert ME; Verola O; Servant JM; Baccard M; Billotey C; Bustamante K; Vandici FO; Basset-Seguin N; Ollivaud L; Morel P; Lebbé C
    Ann Chir Plast Esthet; 2007 Feb; 52(1):14-23. PubMed ID: 17141391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
    Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
    Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full-thickness grafts procured from skin overlying the sentinel lymph node basin; reconstruction of primary cutaneous malignancy excision defects.
    Lewis JM; Zager JS; Yu D; Pelaez D; Riker AI; Dessureault S; Cruse CW; Reintgen DS; Puleo CA; Sondak VK
    Ann Surg Oncol; 2008 Jun; 15(6):1733-40. PubMed ID: 18379848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of sentinel lymph node biopsy in Merkel cell carcinoma. Analysis of 11 cases].
    Blom A; Kolb F; Lumbroso J; Duvillard P; Mamelle G; Morzli K; Ricard M; Spatz A; Petrow P; Margulis A; Avril MF
    Ann Dermatol Venereol; 2003 Apr; 130(4):417-22. PubMed ID: 12843852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sentinel node navigation surgery in melanoma and non-melanoma malignant skin tumor].
    Kiyohara Y; Yoshikawa S; Fujiwara N; Otsuka M; Nakagawa M; Yamamoto A; Saida T
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1191-4. PubMed ID: 16121928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
    Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
    Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node biopsy and completion lymph node dissection for malignant melanoma are not standard of care.
    Coldiron BM; Dinehart S; Rogers HW
    Clin Dermatol; 2009; 27(4):350-4. PubMed ID: 19539161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
    Sabel MS; Griffith KA; Arora A; Shargorodsky J; Blazer DG; Rees R; Wong SL; Cimmino VM; Chang AE
    Surgery; 2007 Jun; 141(6):728-35. PubMed ID: 17560249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy.
    Morris KT; Busam KJ; Bero S; Patel A; Brady MS
    Ann Surg Oncol; 2008 Jan; 15(1):316-22. PubMed ID: 18004626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
    Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology.
    Creager AJ; Shiver SA; Shen P; Geisinger KR; Levine EA
    Cancer; 2002 Jun; 94(11):3016-22. PubMed ID: 12115392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.